111 related articles for article (PubMed ID: 27050515)
1. Uhrf1 Controls iNKT Cell Survival and Differentiation through the Akt-mTOR Axis.
Cui Y; Chen X; Zhang J; Sun X; Liu H; Bai L; Xu C; Liu X
Cell Rep; 2016 Apr; 15(2):256-63. PubMed ID: 27050515
[TBL] [Abstract][Full Text] [Related]
2. mTOR and its tight regulation for iNKT cell development and effector function.
Yang W; Gorentla B; Zhong XP; Shin J
Mol Immunol; 2015 Dec; 68(2 Pt C):536-45. PubMed ID: 26253278
[TBL] [Abstract][Full Text] [Related]
3. Mammalian target of rapamycin complex 1 orchestrates invariant NKT cell differentiation and effector function.
Zhang L; Tschumi BO; Corgnac S; Rüegg MA; Hall MN; Mach JP; Romero P; Donda A
J Immunol; 2014 Aug; 193(4):1759-65. PubMed ID: 25015820
[TBL] [Abstract][Full Text] [Related]
4. Invariant NKT cells require autophagy to coordinate proliferation and survival signals during differentiation.
Pei B; Zhao M; Miller BC; Véla JL; Bruinsma MW; Virgin HW; Kronenberg M
J Immunol; 2015 Jun; 194(12):5872-84. PubMed ID: 25926673
[TBL] [Abstract][Full Text] [Related]
5. iNKT cells require TSC1 for terminal maturation and effector lineage fate decisions.
Wu J; Yang J; Yang K; Wang H; Gorentla B; Shin J; Qiu Y; Que LG; Foster WM; Xia Z; Chi H; Zhong XP
J Clin Invest; 2014 Apr; 124(4):1685-98. PubMed ID: 24614103
[TBL] [Abstract][Full Text] [Related]
6. Applying the TOR(C)QUE in iNKT cells: A new twist in an old tale.
Verykokakis M; Kee BL
Eur J Immunol; 2017 Mar; 47(3):454-457. PubMed ID: 28295259
[TBL] [Abstract][Full Text] [Related]
7. Mammalian target of rapamycin complex 2 regulates invariant NKT cell development and function independent of promyelocytic leukemia zinc-finger.
Prevot N; Pyaram K; Bischoff E; Sen JM; Powell JD; Chang CH
J Immunol; 2015 Jan; 194(1):223-30. PubMed ID: 25404366
[TBL] [Abstract][Full Text] [Related]
8. Hippo/Mst signaling coordinates cellular quiescence with terminal maturation in iNKT cell development and fate decisions.
Raynor JL; Liu C; Dhungana Y; Guy C; Chapman NM; Shi H; Neale G; Sesaki H; Chi H
J Exp Med; 2020 Jun; 217(6):. PubMed ID: 32289155
[TBL] [Abstract][Full Text] [Related]
9. [Recent studies on PI3K/AKT/mTOR signaling pathway in hematopoietic stem cells].
Zhang YC; Cheng T; Yuan WP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):245-9. PubMed ID: 23484729
[TBL] [Abstract][Full Text] [Related]
10. Cutting edge: Discrete functions of mTOR signaling in invariant NKT cell development and NKT17 fate decision.
Wei J; Yang K; Chi H
J Immunol; 2014 Nov; 193(9):4297-4301. PubMed ID: 25261481
[TBL] [Abstract][Full Text] [Related]
11. mTOR Inhibition Per Se Induces Nuclear Localization of FOXP3 and Conversion of Invariant NKT (iNKT) Cells into Immunosuppressive Regulatory iNKT Cells.
Huijts CM; Schneiders FL; Garcia-Vallejo JJ; Verheul HM; de Gruijl TD; van der Vliet HJ
J Immunol; 2015 Sep; 195(5):2038-45. PubMed ID: 26238486
[TBL] [Abstract][Full Text] [Related]
12. Metabolic regulator Fnip1 is crucial for iNKT lymphocyte development.
Park H; Tsang M; Iritani BM; Bevan MJ
Proc Natl Acad Sci U S A; 2014 May; 111(19):7066-71. PubMed ID: 24785297
[TBL] [Abstract][Full Text] [Related]
13. Piperlongumine, an alkaloid causes inhibition of PI3 K/Akt/mTOR signaling axis to induce caspase-dependent apoptosis in human triple-negative breast cancer cells.
Shrivastava S; Kulkarni P; Thummuri D; Jeengar MK; Naidu VG; Alvala M; Redddy GB; Ramakrishna S
Apoptosis; 2014 Jul; 19(7):1148-64. PubMed ID: 24729100
[TBL] [Abstract][Full Text] [Related]
14. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J
Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113
[TBL] [Abstract][Full Text] [Related]
15. SLAM-SAP-Fyn: Old Players with New Roles in iNKT Cell Development and Function.
Bahal D; Hashem T; Nichols KE; Das R
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31569599
[TBL] [Abstract][Full Text] [Related]
16. The differential roles of mTOR, ERK, and JNK pathways in invariant natural killer T-cell function and survival.
Tian J; Liu L; Wang X; Sun X; Mu S; Wu C; Han M
Inflammation; 2014 Dec; 37(6):2013-9. PubMed ID: 24858726
[TBL] [Abstract][Full Text] [Related]
17. Differential dependence on nuclear factor-κB-inducing kinase among natural killer T-cell subsets in their development.
Noma H; Eshima K; Satoh M; Iwabuchi K
Immunology; 2015 Sep; 146(1):89-99. PubMed ID: 25988531
[TBL] [Abstract][Full Text] [Related]
18. PI3-kinase/Akt/mTOR signaling: impaired on/off switches in aging, cognitive decline and Alzheimer's disease.
O' Neill C
Exp Gerontol; 2013 Jul; 48(7):647-53. PubMed ID: 23470275
[TBL] [Abstract][Full Text] [Related]
19. Bidirectional regulation of nuclear factor-κB and mammalian target of rapamycin signaling functionally links Bnip3 gene repression and cell survival of ventricular myocytes.
Dhingra R; Gang H; Wang Y; Biala AK; Aviv Y; Margulets V; Tee A; Kirshenbaum LA
Circ Heart Fail; 2013 Mar; 6(2):335-43. PubMed ID: 23395931
[TBL] [Abstract][Full Text] [Related]
20. Embelin inhibits growth and induces apoptosis through the suppression of Akt/mTOR/S6K1 signaling cascades.
Kim SW; Kim SM; Bae H; Nam D; Lee JH; Lee SG; Shim BS; Kim SH; Ahn KS; Choi SH; Sethi G; Ahn KS
Prostate; 2013 Feb; 73(3):296-305. PubMed ID: 22887478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
